Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VEEVA

Veeva Systems is the leader in cloud-based business solutions for the global life sciences industry. Our customers achieve the fastest time to value through the deployment of fully functional business applications that are flexible to change, simple to deploy, inexpensive to operate and provide a superior user experience.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

VEEVA
Avinguda Diagonal 420, 2º 1ª C.P, 08037 Barcelona, Spain
+34 931 870 200
Contact VEEVA
Website

 Latest Content from PMHub 

Delivering multi-stakeholder patient journey insights in oncology with creative outputs and data visualisation

White Papers and Resources | November 23, 2016 | Inizio

Two clients were co-developing a product and needed to understand the patient journey in two areas of oncology, in order to identify the leverage points where they could provide an...

Webinar: Understanding Patient Willingness to Pay

White Papers and Resources | November 23, 2016 | Inizio

What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?

Research Partnership welcomes 22 new Graduates

White Papers and Resources | November 23, 2016 | Inizio

As part of our continued growth, we are delighted to announce a new intake of 17 Research Analysts and 5 Fieldwork Project Coordinators into our annual market research graduate programme.http://www.researchpartnership.com/news/2016/09/new-graduates-2016/

Case study: Tracking a product launch in a dynamic and competitive market

White Papers and Resources | November 23, 2016 | Inizio

With the imminent expected approval and launch of a new product, our client needed to conduct global tracking research to understand knowledge, perceptions, awareness and recall around their product and the quality...

Understanding the Chronic Disease Patient Journey in Emerging Markets

White Papers and Resources | November 23, 2016 | Inizio

The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by...

Latest wave of Therapy Watch IBD to run this month

White Papers and Resources | November 23, 2016 | Inizio

The IBD syndicated market tracker is part of our large auto-immune portfolio

Research Partnership launches new patient report – Living with Lupus (SLE)

White Papers and Resources | November 23, 2016 | Inizio

Living with Lupus (SLE) is a quantitative study conducted online amongst patients in the US and European markets. The report will consist of 30-minute face to face interviews with a...

Webinar: Ensuring an Actionable Segmentation

White Papers and Resources | November 23, 2016 | Inizio

A segmentation study comes with high visibility and high stakes across your marketing and sales organisations. Ensuring that a segmentation is actionable is a consistent issue, particularly when stakeholders with multiple...

Interactive infographic: LATAM

White Papers and Resources | November 23, 2016 | Inizio

An overview of the six most-commonly researched, largest pharma markets in Latin America

Immuno-oncology: The market opportunity for PD-1/PD-L1s

White Papers and Resources | November 23, 2016 | Inizio

Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies,...